𧬠ICD-10 CM H35.021 β Exudative Retinopathy, Right Eye
Billable Code Confirmed
ICD-10 CM H35.021 is a fully specified 6-character code: category H35 (other retinal disorders) β subcategory H35.0 (background retinopathy/vascular changes) β H35.02 (exudative retinopathy) β 6th character 1 for right eye laterality. No further characters are required for reimbursement.
Non-Billable Parent Codes
H35 β category header only, lacks laterality and subtype specificity, not billable.
H35.0 β subcategory header, still missing the vascular-change subtype, not billable.
H35.02 β specifies exudative retinopathy but omits laterality; a payer will reject this 5-character code and require H35.021/.022/.023/.029.
Clinical Context
The laterality character is the clinical distinction that matters here β right (1), left (2), bilateral (3), or unspecified (9) eye. Documentation must explicitly identify the affected eye(s), or coders default to unspecified (H35.029), which invites a CDI query.
Code Classification
ICD-10 CM H35.021 is a diagnosis code (ICD-10-CM), not a procedure code. It describes the retinal pathology itself and is frequently paired with a CPT/ICD-10-PCS destruction or injection code to justify medical necessity for treatment.
π Code Description
Exudative retinopathy describes a retinal vascular process in which abnormal, leaky vessels allow lipid, protein, and fluid to escape into the H35.021 retina and subretinal space. The underlying pathology is a group of rare, idiopathic, congenital retinal vascular anomalies affecting the retinal capillaries, characterized by dilation and tortuosity of retinal vessels and formation of multiple aneurysms with varying degrees of leakage and exudates. This clinical picture is most classically associated with Coats disease but also captures other non-diabetic exudative vasculopathies affecting the retina.
Coding accuracy hinges on distinguishing H35.02- from the diabetic retinopathy combination codes and from age-related macular degeneration codes like the H35.3211 family, since all three can present with exudation but require entirely different code selections. When exudation occurs secondary to diabetes, the diabetic combination code is sequenced first per the Excludes2 instructional note, with H35.021 reported as an additional code only if the documentation supports a distinct, separately identifiable exudative process.
π³ Code Tree / Hierarchy
H35 Other retinal disorders β Non-billable
β
βββ H35.00 Unspecified background retinopathy β
Billable
βββ H35.01 Changes in retinal vascular appearance β Non-billable (parent)
β β
β βββ H35.011 Changes in retinal vascular appearance, right eye β
Billable
β βββ H35.012 Changes in retinal vascular appearance, left eye β
Billable
β
βββ H35.02 Exudative retinopathy β Non-billable (parent)
β β
β βββ H35.021 Exudative retinopathy, right eye β THIS CODE β
Billable
β βββ H35.022 Exudative retinopathy, left eye β
Billable
β βββ H35.023 Exudative retinopathy, bilateral β
Billable
β βββ H35.029 Exudative retinopathy, unspecified eye β
Billable
β
βββ H35.03 Hypertensive retinopathy β Non-billable (parent)Laterality Drives Reimbursement
Never report the 5-character H35.02 stem β payers require the 6th character. If the operative or clinic note doesnβt specify eye, query the provider before defaulting to H35.029, since unspecified-eye coding on a repeat basis is a common target for payer specificity audits.
Tip
When exudative retinopathy is documented alongside a retinal vascular anomaly consistent with Coats disease terminology, H35.021 remains the correct code β there is no separate combination code for Coats disease in ICD-10-CM.
β Includes
- Right eye exudative retinal vasculopathy consistent with Coats disease or Coats-type retinal telangiectasia, non-diabetic in etiology.
- Peripheral exudative hemorrhagic chorioretinopathy of the right eye, per AAPC coding guidance, when documentation supports this diagnosis over a macular degeneration code.
- Idiopathic exudative retinal vascular anomalies of the right eye not otherwise attributable to diabetes, hypertension, or age-related macular degeneration.
β Excludes
Excludes 1
ICD-10 CM H35.051 β Retinal neovascularization, right eye, unspecified β mutually exclusive when neovascularization rather than exudation is the primary documented finding; the providerβs descriptive language (βleakage/exudateβ vs. βnew vessel growthβ) should drive code selection.
Danger
The most common Excludes1 error is coding both H35.021 and H35.051 for the same right-eye finding when the documentation actually describes a single overlapping process β review the fluorescein angiography report to confirm which feature (exudation vs. neovascularization) is clinically dominant before assigning both.
Excludes 2
Diabetic retinal disorders, e.g. E11.3511 β when exudative retinopathy occurs as a manifestation of diabetes, both the diabetic combination code and H35.021 may be reported together, with the diabetic code sequenced first.
H35.3211 β Exudative age-related macular degeneration, right eye β both codes may be used when a distinct AMD process coexists with a separately documented exudative retinopathy elsewhere in the retina.
π Clinical Overview
Exudative vs. Diabetic vs. Neovascular Retinal Findings
Distinguishing H35.021 from diabetic and neovascular codes matters for both clinical accuracy and combination-code sequencing rules, since payers deny claims where the wrong retinal code family is selected relative to documented etiology.
| Feature | H35.021 | Related H35.051 | Related E11.3511 |
|---|---|---|---|
| Primary process | Vascular leakage/exudate, non-diabetic | New vessel growth (neovascularization) | Diabetes-driven microvascular exudative change |
| Typical etiology | Idiopathic/Coats-type vasculopathy | Ischemia-driven angiogenesis | Chronic hyperglycemia-related microvascular damage |
| Sequencing rule | Stand-alone unless diabetic combo applies | Stand-alone or with PDR codes | Combination code sequenced first |
Important
CDI should query when a note says βretinal exudatesβ without specifying diabetic status β this single documentation gap determines whether H35.021 stands alone or whether a diabetic combination code must be sequenced ahead of it.
Manifestations & Symptom Burden
Blurred or distorted central vision when exudation involves the macula.
Metamorphopsia (visual distortion) from subretinal fluid displacing photoreceptors.
Yellow-white lipid exudates visible on dilated fundus exam, often in a circinate ring pattern.
Exudative retinal detachment in advanced/untreated cases.
Tip
Document vision loss or detachment as separate manifestation codes only when clinically distinct and independently documented β donβt assume detachment from the retinopathy code alone.
π° HCC Risk Adjustment
| Model | HCC Mapping | RAF Impact |
|---|---|---|
| CMS-HCC v28 (2026) | Not Mapped | None |
| RxHCC | Not Mapped | None |
Info
ICD-10 CM H35.021 carries no direct RAF weight under the current CMS-HCC v28 model used for Medicare Advantage risk adjustment. Capturing it correctly still matters for clinical specificity, MS-DRG grouping accuracy, and to support medical necessity documentation for any associated retinal procedure β but coders should not expect this code to influence a patientβs risk score in isolation.
π₯ MS-DRG Assignment
| DRG | Description | CC/MCC Requirement |
|---|---|---|
| 124 | Other Disorders of the Eye with MCC | Requires qualifying MCC elsewhere on claim |
| 125 | Other Disorders of the Eye without MCC | Default when no MCC present |
ICD-10 CM H35.021 groups to MDC 02 (Eye) under MS-DRG. As a principal diagnosis itβs uncommon β this code more typically appears as a secondary diagnosis supporting medical necessity for a same-admission ophthalmic procedure. DRG weight shift comes from the presence of an unrelated MCC on the same claim, not from the retinopathy code itself. No national NCD directly governs H35.021; LCD coverage (where applicable) attaches to the associated CPT procedure code (e.g., photocoagulation), not to the diagnosis code in isolation β verify the local MACβs retinal destruction LCD for medical necessity documentation requirements before billing the procedure.
π Related ICD-10-CM Codes
Same H35.02 family (laterality variants):
H35.022 β Exudative retinopathy, left eye
H35.023 β Exudative retinopathy, bilateral
H35.029 β Exudative retinopathy, unspecified eye
Differential/associated retinal codes:
H35.051 β Retinal neovascularization, right eye, unspecified
H35.3211 β Exudative age-related macular degeneration, right eye, stage unspecified
E11.3511 β Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye
H33.001 β Retinal detachment with retinal break, right eye
π οΈ Commonly Associated CPT Codes
67210 β Destruction of localized lesion of retina by photocoagulation; the primary treatment code when exudative lesions are focally treated with laser.
67228 β Treatment of extensive or progressive retinopathy by photocoagulation; used when exudative changes are diffuse rather than a single focal lesion.
67229 β Treatment of extensive/progressive retinopathy in preterm infants (<37 weeks, up to age 1), by photocoagulation or cryotherapy β relevant if the exudative picture is ROP-related in a neonatal inpatient stay.
92235 β Fluorescein angiography; typically performed to confirm and map the exudative vascular pattern prior to laser treatment.
76512 β Ophthalmic B-scan ultrasound; used when exudation is dense enough to obscure a direct fundus view.
NCCI Bundling Considerations
CPT 67210 and 67228 are mutually exclusive for the same eye on the same date of service β you bill focal (67210) or extensive/panretinal (67228) treatment, not both, for a single laser session. Diagnostic fluorescein angiography (92235) performed on the same day purely to guide the laser session is typically bundled into the procedure and requires modifier -59/-XU with clear documentation of medical necessity to unbundle.
π¬ ICD-10-PCS Crosswalk
085E3ZZ β Destruction of Right Retina, Percutaneous Approach β captures laser photocoagulation of the right retina performed via a contact lens/percutaneous laser delivery, the most common inpatient PCS crosswalk for treating H35.021.
085EXZZ β Destruction of Right Retina, External Approach β used when the destruction technique is documented as an external (non-percutaneous) approach rather than percutaneous laser delivery; confirm against your facilityβs approach-definition policy.
08533ZZ β Destruction of Right Eye, Percutaneous Approach β a less-specific eye-level code; avoid this in favor of the retina-specific body part character (E) whenever the operative note clearly documents retinal-level destruction.
π Coding Scenarios and Examples
Scenario 1 β Inpatient laser treatment for Coats-type exudation:
A 9-year-old is admitted for exam under anesthesia and laser photocoagulation for progressive right-eye exudative retinopathy consistent with Coats disease.
- Codes: H35.021 (principal or secondary diagnosis depending on admission reason),
085E3ZZ(ICD-10-PCS), CPT 67228 for the professional/outpatient claim if applicable. - Sequencing: H35.021 supports medical necessity for the destruction procedure; no diabetic combination code applies since etiology is non-diabetic.
Scenario 2 β Exudative retinopathy secondary to diabetes:
Inpatient with known type 2 diabetes develops right-eye exudative changes documented as diabetes-related.
- Codes: E11.3511 (diabetic combination code, sequenced first), H35.021 (additional code, reported per Excludes2 instruction) only if the exudative process is separately and distinctly documented beyond the diabetic retinopathy description.
- CDI note: query if documentation doesnβt clearly differentiate a distinct exudative component from routine diabetic microvascular changes β otherwise H35.021 may be redundant.
Scenario 3 β Bilateral vs. unilateral documentation gap:
Admission note states βexudative retinopathyβ without laterality; the ophthalmology consult later specifies right eye only.
- Codes: H35.021 once laterality is confirmed in the consult note β do not default to H35.029 if a later, more specific note in the same encounter clarifies the affected eye.
- CDI note: use the most specific documentation available anywhere in the chart, not just the admitting note.
β οΈ Coding Pitfalls and Tips
Pitfall #1: Reporting the non-billable stem H35.02 instead of the laterality-specific 6-character code β this will reject on submission.
Pitfall #2: Defaulting to H35.029 (unspecified eye) when a later note in the same chart specifies laterality β always scan the full encounter before finalizing.
Pitfall #3: Sequencing H35.021 ahead of a diabetic combination code like E11.3511 when diabetes is the documented etiology β the diabetic code must lead per the Excludes2 instruction.
Pitfall #4: Confusing H35.021 with H35.3211 (exudative AMD) β verify whether the documentation supports age-related macular degeneration specifically versus a broader/non-AMD exudative process before code selection.
Pitfall #5: Mismatching diagnosis and procedure laterality β if H35.021 (right eye) is on the claim but the PCS/CPT procedure code documents the left eye, expect a payer edit.
π Sources
1. ICD10Data.com. *2026 ICD-10-CM Diagnosis Code H35.021 β Exudative retinopathy, right eye.* Centers for Medicare & Medicaid Services / National Center for Health Statistics; 2026. 2. ICD10Data.com. *2026 ICD-10-CM Diagnosis Code H35.02 β Exudative retinopathy.* CMS/NCHS; 2026. 3. AAPC/Codify. *ICD-10 Code for Exudative Retinopathy β H35.02.* AAPC; 2026. 4. CMS.gov. *MS-DRG v42.0/v43.0 Definitions Manual β MDC 02, DRG 124/125.* Centers for Medicare & Medicaid Services; 2026. 5. Retina Today. *Properly Coding Retina Surgeries.* 2019 (CPT code descriptions verified current for 2026). 6. ICD10Data.com. *2026 ICD-10-PCS Procedure Code 085E3ZZ β Destruction of Right Retina, Percutaneous Approach.* CMS/NCHS; 2026.Sources listed above correspond to superscript citations throughout this note. Verify all Medicare payment figures against your current CMS PFS Lookup tool and applicable MAC LCD prior to claim submission. Please use the latest AAPC/AHIMA Coding Books to verify each code within this note.